Thiol disulfide homeostasis in primary dysmenorrhea

Oxidative stress is defined as a result of the loss of balance between the production of free radical or reactive oxygen species and the antioxidant system. This study aimed to determine the level of thiol-disulfide homeostasis (TDH) in the serum of women with primary dysmenorrhea. The study group consisted of 42 subjects with primary dysmenorrhea, and the control group consisted of 30 volunteer women with demographic characteristics similar to the study group. Native thiol (SH), total thiol (TSH), disulphide (SS), and SH/SS parameters were measured for TDH of the subjects. The SH (p = 0.038) and SH/TSH (p = 0.046) levels were significantly higher while SS (p = 0.013), SS/SH (p = 0.042) and SS/TSH (p = 0.046) levels were lower in the study group than in the healthy control group. The SS cut-off value was determined as 17.85 in the study group (sensitivity = 61.9%, specificity = 43.3%). Therefore, the probability of dysmenorrhea may increase significantly when SS levels fall below this value. In subjects with dysmenorrhea, there was a decrease in SS levels and an increase in SH levels in order to protect the cells and tissues from the harmful effects of free radicals.

Primary dysmenorrhea; Thiol-disulfide; Oxidative stress; ROC analysis; TDH

[1] Karabulut H, Gülay MŞ. Serbest Radikaller Free Radicals. Mehmet Akif Ersoy Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2016; 4: 50–59.

[2] Fang Y, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002; 18: 872–879.

[3] Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clinical Biochemistry. 2014; 47: 326–332.

[4] Eren Y, Dirik E, Neşelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurologica Belgica. 2015; 115: 643–649.

[5] Sönmez MG, Kozanhan B, Deniz ÇD, Göger YE, Kılınç MT, Neşeliogˇlu S, et al. Is oxidative stress measured by thiol/disulphide homeostasis status associated with prostate adenocarcinoma? Central European Journal of Immunology. 2018; 43: 174–179.

[6] Turkyilmaz E, Yildirim M, Cendek BD, Baran P, Alisik M, Dalgaci F, et al. Evaluation of oxidative stress markers and intra-extracellular antioxidant activities in patients with endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2016; 199: 164–168.

[7] Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Research. 2017; 6: 1645.

[8] Omani Samani R, Almasi Hashiani A, Razavi M, Vesali S, Rezaeinejad M, Maroufizadeh S, et al. The prevalence of menstrual disorders in Iran: a systematic review and meta-analysis. International Journal of Reproductive Biomedicine. 2018; 16: 665–678.

[9] Jiang Z, Wang J, Guo X, Feng L, Yu M, Zhou J, et al. Menstrual disorders and occupational exposures among female nurses: a nationwide cross-sectional study. International Journal of Nursing Studies. 2019; 95: 49–55.

[10] Silva GD, Canova NAH, Bortoletto P, Wutzke MLS, Soares F dos S, Bertolini GRF. Cryotherapy Produces Pain Relief in Young People with Primary Dysmenorrhea. Therapeutic Hypothermia and Temperature Management. 2021. (in press)

[11] Harada T. Dysmenorrhea and endometriosis in young women. Yonago Acta Medica. 2013; 56: 81–84.

[12] Yuan L, Lin D, Kang X, Ye Y. Shaofu Zhuyu decoction for primary dysmenorrhea. Medicine. 2021; 100: e26226.

[13] Morrow C, Naumburg EH. Dysmenorrhea. Primary Care. 2009; 36: 19–32.

[14] Liu Y, Yao L, Yan B, Jiang H, Zhao J, Cao J, et al. The effectiveness of acupoint application of traditional Chinese medicine in treating primary dysmenorrhea. Medicine. 2021; 100: e26398.

[15] Evans S, Dowding C, Olive L, Payne LA, Druitt M, Seidman LC, et al. Pain catastrophizing, but not mental health or social support, is associated with menstrual pain severity in women with dysmenorrhea: A cross-sectional survey. Psychology, Health & Medicine. 2021. (in press)

[16] Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology. 2006; 108: 428–441.

[17] Turhan N, Celik H, Duvan Cİ, Onaran Y, Aydın M, Armutcu F. Investigation of oxidative balance in patients with dysmenorrhea by multiple serum markers. Journal of the Turkish German Gynecological Association. 2012; 13: 233–236.

[18] Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Medicine and Cellular Longevity. 2017; 2017: 8416763.

[19] Dikensoy E, Balat O, Pençe S, Balat A, Cekmen M, Yurekli M. Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea. Journal of Obstetrics and Gynaecology Research. 2008; 34: 1049–1053.

[20] Szmidt MK, Granda D, Sicinska E, Kaluza J. Primary Dysmenorrhea in Relation to Oxidative Stress and Antioxidant Status: A Systematic Review of Case-Control Studies. Antioxidants. 2020; 9: 994.

[21] Adeyemi A, Adekanle D. Management Of Dysmenorrrhoea Among Medical Students. The Internet Journal of Gynecology and Obstetrics. 2007; 7.

[22] Korkmaz V, Kurdoglu Z, Alisik M, Cetin O, Korkmaz H, Surer H, et al. Impairment of thiol-disulfide homeostasis in preeclampsia. Journal of Maternal-Fetal & Neonatal Medicine. 2016; 29: 3848–3853.

[23] Larroy C. Comparing visual-analog and numeric scales for assessing menstrual pain. Behavioral Medicine. 2002; 27: 179–181.

[24] Akdemir N, Cinemre FB, Bostancı MS, Cinemre H, Ünal O, Ozden S, et al. The correlation of serum asymmetric dimethylarginine and anti-Müllerian hormone in primary dysmenorrhea. The Kaohsiung Journal of Medical Sciences. 2016; 32: 414–419.

[25] Trotta E, Bortolotti S, Fugazzotto G, Gellera C, Montagnese S, Amodio P. Familial vitamin E deficiency: Multiorgan complications support the adverse role of oxidative stress. Nutrition. 2019; 63-64: 57–60.

[26] Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Medical Journal. 2004; 45: 776–788.

[27] Parcell S. Sulfur in human nutrition and applications in medicine. Alternative Medicine Review. 2002; 7: 22–44.

[28] Kelly GS. Clinical applications of N-acetylcysteine. Alternative Medicine Review : a Journal of Clinical Therapeutic. 1998; 3: 114–127.

[29] Yeh M, Chen H, So EC, Liu C. A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan. Life Sciences. 2004; 75: 669–673.

[30] Kaplan Ö, Nazıroğlu M, Güney M, Aykur M. Non-steroidal anti-inflammatory drug modulates oxidative stress and calcium ion levels in the neutrophils of patients with primary dysmenorrhea. Journal of Reproductive Immunology. 2013; 100: 87–92.

[31] Menteşe Ü, Turan İ, Doğan S, Sümer A, Coşkun C, Alver A, et al. Evaluation of oxidative stress balance in acute deep vein thrombosis. Turkish Journal of Biochemistry. 2015; 40: 51–57.